Testing 104 cervical cancers from Curaçao, the authors found HPV types 16 and 18 in a smaller share than worldwide, with other high-risk types making a relatively large contribution, which matters for the choice of vaccine.
Published as "High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine". Paraffin blocks of 104 cervical cancers and 120 precancerous lesions were analysed for HPV genotypes. The full text cites the Cancer Registry of Curaçao for a cervical cancer incidence of 13.4 per 100,000 women in 2004 to 2008, and says HPV vaccines were then not part of a national vaccination programme.
The authors say the relatively high contribution of HPV types other than 16 and 18 should be taken into account when considering HPV vaccination in Curaçao.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/